Learn how neurologists use migraine diary data, including frequency, disability scores, and treatment response, to make better clinical decisions for you.
How doctors use migraine data is not a mystery, but it is often underappreciated by patients who dutifully track their headaches and then hand over a phone screen in the exam room. When organized thoughtfully, your migraine log is a clinical instrument. It tells your neurologist things you cannot reliably convey from memory, shapes the decisions they make at every appointment, and increasingly determines what your insurer will cover. Understanding the clinical perspective on migraine data helps you collect the right things, present them clearly, and get more out of every visit.
Every neurology appointment for migraine has roughly the same underlying clinical agenda, even when it feels like a routine check-in. Your provider is silently asking:
All five are answered faster and more accurately with logged data than with verbal summaries. Memory is unreliable for pain frequency: most people undercount migraine days and overestimate gaps between attacks. Clinicians know this, which is why a well-kept migraine diary is treated as a more credible source than recall.
Not all migraine tracking data carries equal clinical weight. Below is a breakdown of the specific signals neurologists and headache specialists prioritize, and why each one matters.
| Data Point | What Clinicians Use It For |
|---|---|
| Monthly migraine day (MMD) count | Classifying episodic vs. chronic migraine; tracking treatment response over time |
| Headache day count (total) | Distinguishing true migraine days from non-migraine headache days |
| Acute medication use days | Screening for medication overuse headache (MOH); evaluating rescue med burden |
| Pain severity (scale of 1 to 10) | Gauging whether severity shifts alongside frequency on a new treatment |
| Attack duration | Understanding disease burden; identifying unusually prolonged episodes |
| MIDAS score | Quantifying disability across work, household tasks, and social activity |
| HIT-6 score | Measuring headache impact on daily functioning and quality of life |
| Adherence to preventive treatment | Contextualizing response data; ruling out non-adherence as a confounder |
| Potential trigger patterns | Identifying modifiable contributors to attack frequency |
Understanding what each score actually measures is worth the few minutes it takes. If you want a detailed breakdown of how MIDAS and HIT-6 are scored and interpreted, MIDAS and HIT-6 explained covers the methodology and what the numbers mean clinically.
Before any treatment can be evaluated, a clinician needs to know where you started. A baseline typically means two to three months of pre-treatment tracking: monthly migraine day count, acute medication days, and a baseline disability score. Without this, there is no meaningful "before" to compare to the "after."
This baseline matters more than it might seem. When response is strong the contrast is clear. When it is partial or ambiguous, the quality of the baseline data often determines whether a treatment is adjusted, continued, or switched.
A single MMD count from a month of good tracking tells one story. A continuous log across six or twelve months tells a much richer one. Clinicians look for trends: is frequency gradually creeping upward over months, suggesting transition from episodic to chronic migraine? Is a medication that was working six months ago starting to lose effect? Is there a seasonal or hormonal pattern that might inform treatment timing or dose adjustments?
These patterns are invisible in visit-to-visit memory. They surface clearly in a continuous log and change clinical recommendations. For a deeper look at what counts as a migraine day and why the threshold matters, monthly migraine days explains how clinicians define and count them.
One of the most important things a clinician checks in a migraine log is how frequently acute medications are being used. The clinical threshold for medication overuse headache (MOH) varies by medication class, but the general pattern is: if acute medications are used on 10 to 15 or more days per month for three months or longer, MOH becomes a real concern. Paradoxically, overusing rescue medications can increase headache frequency, creating a cycle that is difficult to break.
A patient who reports "I use my rescue medication maybe two or three times a week" often doesn't realize they are crossing that threshold. A log showing specific medication days per month makes the pattern visible and actionable.
For CGRP preventives specifically, treatment response is not just a clinical question. It is an insurance question. Renewal packets require documented evidence that the medication is working, and that evidence takes a specific form: baseline MMD count, current MMD count, percent reduction, breakthrough medication days, and disability score changes. Measuring CGRP progress explains the specific response benchmarks that matter for both clinical evaluation and coverage renewals.
When a patient walks into a pre-renewal appointment with three months of clean tracking data, their prescriber can build a renewal packet in a fraction of the time it takes with estimated numbers. When that patient also documented their baseline before starting, the before-and-after comparison is concrete rather than reconstructed. CGRP prior authorization renewals covers what a strong renewal packet looks like and why documentation is the most common failure point.
MIDAS and HIT-6 give clinicians a standardized, validated way to quantify how much migraine is affecting your ability to work, handle household tasks, and engage in daily life. A MIDAS score of 35 (severe disability) at baseline and 12 (moderate) at six months is a different kind of clinical signal than "I'm doing better."
Tracking these scores at regular intervals creates a longitudinal disability record that matters for treatment decisions, workplace accommodations, and insurance documentation.
Most neurology appointments for migraine run 20 to 30 minutes. Patients who arrive with a concise summary covering monthly MMD counts, medication use, key trends, and a current disability score make that time more efficient. Clinicians can spend it on reasoning rather than reconstruction.
The inverse is also true: when a patient cannot recall monthly migraine day counts for the past few months, the clinical picture is incomplete and decisions get made on thinner information. For practical advice on presenting this data, how to prepare for your neurologist appointment walks through what to bring and how to frame it.
Migraine is a condition where clinical decisions happen at infrequent intervals but effects play out continuously. The gap between appointments is where your disease actually lives, and neither you nor your clinician can fully see it without a record.
Good data does several things verbal reporting alone cannot:
It removes recall bias. Pain is emotionally encoded. People remember their worst attacks and undercount moderate ones. A log captures the full picture.
It creates accountability for patterns. A spike in medication use over two months is harder to explain away when it is documented day by day.
It enables precise treatment iteration. Small preventive therapy adjustments are much easier to evaluate when you have a clean record of what changed and when.
It protects coverage. For CGRP preventives, your continued access depends on documenting that the treatment is working. The data you collect becomes the evidence your prescriber uses at renewal.
Data that lives only on your phone or in a paper journal is less useful than data that gets to your care team in a format they can actually use. A full chronological log is rarely the right format for a physician. What works is a summary: monthly migraine day counts over three to six months, acute medication days, current disability scores, and the key trend (improving, stable, worsening). For a detailed guide on how to share your migraine log effectively, sharing your migraine log with your doctor covers formats, timing, and what to highlight.
Migraine Tracker: CGRP Log (by PixelPort LLC) is built around the exact data points described above. It generates a one-page renewal-ready report showing baseline versus current monthly migraine days, percent reduction, breakthrough medication days, MIDAS and HIT-6 scores, and adherence, all in a format designed for care team use. You can export a clean PDF or share a passcode-protected, revocable link that your care team can access securely. Everything is encrypted on-device and requires no account. If you want to see the report format, the CGRP renewal report page shows what the export looks like and what gets included.
Educational, not medical advice. Migraine Tracker: CGRP Log is a personal tracking tool, not a medical device. It does not diagnose, treat, or provide medical advice. Always talk to your clinician.
Neurologists look at monthly migraine day frequency, patterns tied to triggers or hormonal cycles, acute medication use, and how disability scores like MIDAS or HIT-6 change over time. They use this data to gauge disease severity, evaluate treatment response, and decide whether to adjust a treatment plan.
Learn how to share your migraine diary with your doctor effectively, what formats work best, and how to protect your privacy while doing it.
A practical checklist of migraine tracker features that matter for clinical accuracy, insurance renewals, and sharing with your care team. What to look for before you commit.
Prepare for your neurologist appointment with a practical migraine checklist. Learn what data to bring, questions to ask, and how to summarize your month effectively.
